INSYS Therapeutics, Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From INSYS Therapeutics, Inc.
Medtech industry group AdvaMed has developed a registry to share data on how many COVID-19 diagnostic tests are available and where they are, with a goal of foreseeing and nipping in the bud potential test shortages. Thirteen diagnostic manufacturers – including Abbott, Roche, Siemens and Thermo Fisher Scientific – have partnered with AdvaMed on the initiative.
Contract development and manufacturing organization relied on combination of immersive mixed-reality devices to host remote inspection.
Hedge fund Davidson Kempner advised Qiagen to ask for a higher acquisition price from Thermo Fisher Sciences as COVID-19 has increased demand for diagnostic products.
AbbVie Japan has seen strong growth for its commercial and R&D portfolios over the past few years, but with flagship product Humira facing its first local biosimilar competition, the company is looking to brand strength and an increased oncology presence to address the challenge.
- In Vitro Diagnostics
- Medical Devices
- Drug Delivery
- OTC, Consumer
- Implantable Devices
- Infusion Therapy Equipment and Supplies
- Gene Therapy, Cell Therapy
- Large Molecule
- Other Names / Subsidiaries
- NeoPharm, Inc.
- Fresenius Biotech GmbH
- Neovii Biotech GmbH